- Title :
- Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment
- Authors :
- Subject Terms :
-
FDG‐PET
KRAS mutation
non‐small‐cell lung cancer
pharmacodynamics
pharmacokinetics
Phase‐I trial
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Source :
- Cancer Medicine, Vol 9, Iss 14, Pp 4991-5007 (2020)
- File Description :
- electronic resource
- Relation :
- https://doaj.org/toc/2045-7634
- Access URL :
- https://doaj.org/article/04f6918ff70742839866e3f4fa056a57
-
Academic Journal